Sung Lee | Gilead Sciences, Inc. |
John F. Milligan | Gilead Sciences, Inc. |
John G. McHutchison | Gilead Sciences, Inc. |
Robin L. Washington | Gilead Sciences, Inc. |
Andrew Cheng | Gilead Sciences, Inc. |
Geoffrey C. Porges | Leerink Partners LLC |
Geoffrey Meacham | Barclays Capital, Inc. |
Michael J. Yee | Jefferies LLC |
Brian Abrahams | RBC Capital Markets LLC |
Matthew K. Harrison | Morgan Stanley & Co. LLC |
Robyn Karnauskas | Citigroup Global Markets, Inc. |
Regina Grebla | Evercore Group LLC |
Philip Nadeau | Cowen & Company |
Terence Flynn | Goldman Sachs & Co. LLC |
Cory W. Kasimov | JPMorgan Securities LLC |
Alethia Young | Credit Suisse Securities (NYSE:USA) LLC |
Salim Syed | Mizuho Securities USA LLC |
Ying Huang | Bank of America Merrill Lynch |
Carter Gould | UBS Securities LLC |
Ladies and gentlemen, thank you for standing by and welcome to the Gilead Sciences first quarter 2018 earnings conference call. My name is Candace, and I will be your conference operator today. At this time, all participants are in a listen-only mode. And as a reminder, this conference call is being recorded. I would now like to turn the call over to Sung Lee, Vice President of Investor Relations.